Effect of Adult Spinal Deformity Surgery on Functional Reach
Launched by UNIVERSITY OF KANSAS MEDICAL CENTER · Feb 5, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how surgery for adult spinal deformity (ASD), such as scoliosis and kyphosis, affects balance and the ability to reach while standing. Many people with ASD struggle with balance, which can make daily activities difficult. Researchers want to create a new test that measures balance more effectively by looking at how far someone can reach while standing, using special sensors and equipment to track movement. By comparing the balance of ASD patients with healthy individuals, the study aims to help doctors understand the risks of balance problems in daily life and improve surgical techniques for better outcomes.
To participate in this study, you need to be at least 18 years old and diagnosed with adult spinal deformity that requires corrective surgery. Ideal candidates can perform daily activities without help and should not have other conditions affecting their spine. Healthy adults without spine issues can also join as a comparison group. Participants will undergo balance tests and assessments, contributing valuable information that could help enhance treatment for future patients with similar conditions.
Gender
ALL
Eligibility criteria
- Adult Spinal Deformity Patient Inclusion Criteria:
- • Adults over the age of 18
- • Diagnosed with adult spinal deformity according to the SRS-Schwab Adult Spinal Deformity Classification System
- • Indicated for deformity corrective surgery including multilevel spinal fusion of three or more levels
- • Lowest instrumented level includes S1 or pelvic fixation
- • Able to perform functional activities without the use of any assistance or support
- • devices
- Adult Spinal Deformity Patient Exclusion Criteria:
- • Indicated for spinal fusion due to spinal tumor, trauma, or infection
- • ASD patients who do not plan to be available for all follow-up evaluations at our institution
- • Pregnancy during any time point within the participation duration
- Asymptomatic Control Participant Inclusion Criteria:
- • Adults over the age of 18
- • No current or prior spine pathology or surgery
- • Able to perform the functional activities without the use of any assistance or support devices
- Asymptomatic Control Participant Exclusion Criteria:
- • Any current or prior spine or lower extremity pathology or surgery that impacts the subject's ability to perform the functional activities
- • Pregnancy at the time of the evaluation
About University Of Kansas Medical Center
The University of Kansas Medical Center (KUMC) is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical practice. As a prominent clinical trial sponsor, KUMC leverages its extensive expertise in diverse medical fields to conduct rigorous clinical research aimed at improving patient outcomes and developing new treatment modalities. With a commitment to ethical standards and patient safety, KUMC collaborates with multidisciplinary teams to facilitate groundbreaking studies that address significant health challenges, ultimately contributing to the advancement of medical knowledge and the enhancement of community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kansas City, Kansas, United States
Patients applied
Trial Officials
Damon Mar
Principal Investigator
University of Kansas Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported